Content about Doshi

October 11, 2010

Generic drug maker Caraco said that its interim CEO and director, Jitendra Doshi, will step...

DETROIT Generic drug maker Caraco said that its interim CEO and director, Jitendra Doshi, will step down from his position Nov. 1 due to personal and health-related reasons.

While Doshi will assist the company in effecting a smooth transition, G. P. Singh will assume the position of CEO, Caraco said. Singh currently serves as Caraco's COO, and previously was SVP business strategies for three years.